UBS Group’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,534
| Closed | -$9K | – | 10435 |
|
|
2022
Q2 | $9K | Sell |
23,534
-43,003
| -65% | -$16.4K | ﹤0.01% | 7213 |
|
|
2022
Q1 | $99K | Buy |
66,537
+20,906
| +46% | +$31.1K | ﹤0.01% | 4926 |
|
|
2021
Q4 | $111K | Buy |
45,631
+6,977
| +18% | +$17K | ﹤0.01% | 5163 |
|
|
2021
Q3 | $206K | Buy |
38,654
+35,546
| +1,144% | +$189K | ﹤0.01% | 4249 |
|
|
2021
Q2 | $31K | Buy |
+3,108
| New | +$31K | ﹤0.01% | 5840 |
|